Atria Investments Inc boosted its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 54.0% during ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report).

WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA ...

Zimmer Biomet appoints Kristen Cardillo as SVP and Chief Communications Officer to lead global strategy and stakeholder engagement.

Zimmer Biomet Holdings, Inc. has a 52 week low of $97.69 and a 52 week high of $133.90. The company has a current ratio of 1.91, a quick ratio of 0.70 and a debt-to-equity ratio of 0.43.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of ...

Zimmer Biomet (ZBH) announced that Jehanzeb Noor is joining the Company as Senior Vice President, SVP, Chief Strategy, Innovation and Business ...

WARSAW, Ind., Feb. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced upcoming changes to the Company's Board of ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, has entered into a strategic distribution agreement with Promamec, a leading provider of medical devices in ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has announced the issuance of a series of new notes totaling $1.75 billion on Wednesday. The medical device company, currently trading near its 52-week low ...

WARSAW, Ind. - Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a notable player in the medical technology industry with a market capitalization of $20.89 billion and impressive gross profit margins of 71 ...